Bausch Health Companies Inc. (BHC)Healthcare | Drug Manufacturers - Specialty & Generic | Laval, Canada | NYSE
4.85 USD
+0.07
(1.464%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 4.80 -0.05 (-0.050%) ⇩ (July 13, 2026, 7:55 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 2:57 a.m. EDT
The long-term investment case is severely compromised by a decade-long structural decline; the stock has lost over 72% of its value since 2016, with the last two years showing consecutive negative returns. Despite a technically low forward P/E, the company is generating negative earnings and trading against a backdrop of deteriorating fundamentals, making it a value trap rather than a bargain. The absence of any dividend history eliminates income potential entirely. On the short end, the price is hovering near its 52-week low, supported by heavy put option positioning that suggests traders are betting on further weakness or a slow grind lower. While the statistical forecast shows a negligible upward lean, it lacks the conviction to overcome the massive fundamental headwinds. The market appears to be waiting for a catalyst to reverse the multi-year downtrend, but until then, the outlook remains bearish. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.093171 |
| AutoARIMA | 0.093172 |
| MSTL | 0.097372 |
| AutoTheta | 0.101091 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 13.75 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.305 |
| Excess Kurtosis | -1.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2010-11-09 |
| Last Dividend Date | 2010-11-09 |
| Revenue per Share | 28.332 |
| Market Cap | 1,811,356,800 |
| Forward P/E | 1.15 |
| Beta | 0.42 |
| Profit Margins | -11.47% |
| Website | https://www.bauschhealth.com |
As of July 11, 2026, 2:57 a.m. EDT: Options activity reveals a distinct 'pinning' bias at the $5.00 strike across nearly all expirations, acting as a psychological floor. While there is notable open interest in deep out-of-the-money calls ($6.00-$7.00) suggesting a speculative hope for a recovery, the overwhelming volume and open interest in puts at strikes below the current price indicate a defensive stance. Speculators are heavily positioned for downside protection rather than aggressive upside moves, with significant put volume concentrated at the $4.00-$4.50 range.
| Date | Dividend | Yield % |
|---|---|---|
| 2010-11-10 | 1.000 | 3.901678 |
| 2010-08-30 | 0.095 | 0.419056 |
| 2010-05-28 | 0.095 | 0.632911 |
| 2010-03-04 | 0.090 | 0.584036 |
| 2009-11-30 | 0.090 | 0.623701 |
| 2009-08-28 | 0.090 | 0.704777 |
| 2009-05-13 | 0.090 | 0.827206 |
| 2009-03-06 | 0.375 | 3.475440 |
| 2008-12-19 | 0.375 | 4.162042 |
| 2008-08-21 | 0.375 | 3.720238 |
| 2008-05-20 | 0.375 | 3.078818 |
| 2008-03-25 | 0.375 | 3.446691 |
| 2007-11-16 | 0.375 | 2.238806 |
| 2007-08-16 | 0.375 | 2.241482 |
| 2007-05-18 | 0.375 | 1.528740 |
| 2007-03-22 | 0.375 | 1.732902 |
| 2007-01-08 | 0.500 | 2.428363 |
| 2006-11-20 | 0.125 | 0.728014 |
| 2006-08-16 | 0.125 | 0.787154 |
| 2006-05-19 | 0.125 | 0.494658 |
| 2006-04-05 | 0.125 | 0.500000 |
| 2005-11-28 | 0.500 | 2.174859 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2460568 |
| Address1 | 2,150 St. Elzéar Blvd. West |
| All Time High | 263.81 |
| All Time Low | 0.354167 |
| Ask | 0.0 |
| Ask Size | 10,000 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 3,548,890 |
| Average Daily Volume3 Month | 2,198,880 |
| Average Volume | 2,198,880 |
| Average Volume10Days | 3,548,890 |
| Beta | 0.418 |
| Bid | 0.0 |
| Bid Size | 6,700 |
| Board Risk | 1 |
| Book Value | -5.513 |
| City | Laval |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.85 |
| Current Ratio | 1.32 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 4.89 |
| Day Low | 4.775 |
| Display Name | Bausch Health Companies |
| Earnings Call Timestamp End | 1,785,355,200 |
| Earnings Call Timestamp Start | 1,785,355,200 |
| Earnings Timestamp | 1,785,355,200 |
| Earnings Timestamp End | 1,785,355,200 |
| Earnings Timestamp Start | 1,785,355,200 |
| Ebitda | 3,614,000,128 |
| Ebitda Margins | 0.34318 |
| Enterprise To Ebitda | 6.166 |
| Enterprise To Revenue | 2.116 |
| Enterprise Value | 22,284,357,632 |
| Eps Current Year | 4.4206 |
| Eps Forward | 4.2172 |
| Eps Trailing Twelve Months | -3.29 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,289,347,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.2018 |
| Fifty Day Average Change | -0.35179996 |
| Fifty Day Average Change Percent | -0.06763043 |
| Fifty Two Week Change Percent | -24.605679 |
| Fifty Two Week High | 8.69 |
| Fifty Two Week High Change | -3.8399997 |
| Fifty Two Week High Change Percent | -0.4418872 |
| Fifty Two Week Low | 4.57 |
| Fifty Two Week Low Change | 0.27999973 |
| Fifty Two Week Low Change Percent | 0.061269086 |
| Fifty Two Week Range | 4.57 - 8.69 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 764,951,400,000 |
| Five Year Avg Dividend Yield | 6.52 |
| Float Shares | 259,957,722 |
| Forward Eps | 4.2172 |
| Forward P E | 1.1500522 |
| Free Cashflow | 1,123,500,032 |
| Full Exchange Name | NYSE |
| Full Time Employees | 20,300 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.71038 |
| Gross Profits | 7,480,999,936 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11139 |
| Held Percent Institutions | 0.65068 |
| Implied Shares Outstanding | 373,475,644 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,289,347,200 |
| Last Dividend Value | 1.0 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 971,654,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. |
| Long Name | Bausch Health Companies Inc. |
| Market | us_market |
| Market Cap | 1,811,356,800 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_345779 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -1,208,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,780,960,843 |
| Number Of Analyst Opinions | 5 |
| Open | 4.78 |
| Operating Cashflow | 1,419,000,064 |
| Operating Margins | 0.20642 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.01 |
| Phone | 514 744 6792 |
| Post Market Change | -0.049999714 |
| Post Market Change Percent | -1.0309219 |
| Post Market Price | 4.8 |
| Post Market Time | 1,783,986,931 |
| Previous Close | 4.78 |
| Price Eps Current Year | 1.0971361 |
| Price Hint | 4 |
| Price To Book | -0.8797388 |
| Price To Sales Trailing12 Months | 0.17200235 |
| Profit Margins | -0.114709996 |
| Quick Ratio | 0.77 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0699997 |
| Regular Market Change Percent | 1.46443 |
| Regular Market Day High | 4.89 |
| Regular Market Day Low | 4.775 |
| Regular Market Day Range | 4.775 - 4.89 |
| Regular Market Open | 4.78 |
| Regular Market Previous Close | 4.78 |
| Regular Market Price | 4.85 |
| Regular Market Time | 1,783,972,802 |
| Regular Market Volume | 1,455,657 |
| Return On Assets | 0.059310004 |
| Revenue Growth | 0.117 |
| Revenue Per Share | 28.332 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 373,475,644 |
| Shares Percent Shares Out | 0.0196 |
| Shares Short | 7,332,632 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 6,124,091 |
| Short Name | Bausch Health Companies Inc. |
| Short Percent Of Float | 0.024600001 |
| Short Ratio | 2.43 |
| Source Interval | 15 |
| State | QC |
| Symbol | BHC |
| Target High Price | 9.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 7.4 |
| Target Median Price | 7.0 |
| Total Cash | 1,299,000,064 |
| Total Cash Per Share | 3.478 |
| Total Debt | 20,795,000,832 |
| Total Revenue | 10,531,000,320 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.29 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.95925 |
| Two Hundred Day Average Change | -1.1092501 |
| Two Hundred Day Average Change Percent | -0.18613921 |
| Type Disp | Equity |
| Volume | 1,455,657 |
| Website | https://www.bauschhealth.com |
| Zip | H7L 4A8 |